Literature DB >> 21316502

Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV.

Debby Kruijsen1, Marcel A Schijf, Michaël V Lukens, Nathalie O van Uden, Jan L Kimpen, Frank E Coenjaerts, Grada M van Bleek.   

Abstract

Inactivated respiratory syncytial virus (RSV) vaccines tend to predispose for immune mediated enhanced disease, characterized by Th2 responses and airway hypersensitivity reactions. We show in a C57BL/6 mouse model that the early innate response elicited by the challenge virus (RSV versus influenza virus) influences the outcome of the Th1/Th2 balance in the lung after intramuscular priming with inactivated vaccine. Priming of CD4(+)/IFN-γ(+) T cells by mature dendritic cells administered intravenously and/or priming of a virus specific CD8(+) T cell response ameliorated the Th2-mediated inflammatory response in the lung, suggesting that vaccination procedures are feasible that prevent vaccine induced immune pathology.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316502     DOI: 10.1016/j.vaccine.2011.01.087

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics.

Authors:  Lydia Tan; Frank E J Coenjaerts; Lieselot Houspie; Marco C Viveen; Grada M van Bleek; Emmanuel J H J Wiertz; Darren P Martin; Philippe Lemey
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

2.  Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection.

Authors:  Daniel S McDermott; Kayla A Weiss; Cory J Knudson; Steven M Varga
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

Review 3.  A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.

Authors:  Emma Rey-Jurado; Jorge Soto; Nicolás Gálvez; Alexis M Kalergis
Journal:  Hum Vaccin Immunother       Date:  2017-06-09       Impact factor: 3.452

4.  Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.

Authors:  Marcel A Schijf; Debby Kruijsen; Jacqueline Bastiaans; Frank E J Coenjaerts; Johan Garssen; Grada M van Bleek; Belinda van't Land
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

5.  Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice.

Authors:  Debby Kruijsen; Helga K Einarsdottir; Marcel A Schijf; Frank E Coenjaerts; Ellen C van der Schoot; Gestur Vidarsson; Grada M van Bleek
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

6.  Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiology.

Authors:  Lydia Tan; Philippe Lemey; Lieselot Houspie; Marco C Viveen; Nicolaas J G Jansen; Anton M van Loon; Emmanuel Wiertz; Grada M van Bleek; Darren P Martin; Frank E Coenjaerts
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

7.  Immunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouse.

Authors:  Hsiao-Yun Shao; Yi-Wen Lin; Shu-Ling Yu; Hsiang-Yin Lin; Ebenezer Chitra; Yung-Chen Chang; Charles Sia; Pele Chong; Ming-Tao Hsu; Olivia L Wei; Yen-Hung Chow
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

8.  Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.

Authors:  Mary J G van Helden; Peter J S van Kooten; Cornelis P J Bekker; Andrea Gröne; David J Topham; Andrew J Easton; Claire J P Boog; Dirk H Busch; Dietmar M W Zaiss; Alice J A M Sijts
Journal:  Vaccine       Date:  2012-08-29       Impact factor: 3.641

Review 9.  Dendritic cells in human Pneumovirus and Metapneumovirus infections.

Authors:  Antonieta Guerrero-Plata
Journal:  Viruses       Date:  2013-06-20       Impact factor: 5.048

10.  A virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A provides protection against viral challenge without priming for enhanced disease in cotton rats.

Authors:  Tobias Kamphuis; Toon Stegmann; Tjarko Meijerhof; Jan Wilschut; Aalzen de Haan
Journal:  Influenza Other Respir Viruses       Date:  2013-04-10       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.